Michael Deininger
Impact in
-
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 1
-
- Chronic Myeloid Leukemia Treatments 5
- Co-authors
- John M. Goldman (1 shared paper)Joanna Góra‐Tybor (1 shared paper)Junia V. Melo (1 shared paper)Dietger Niederwieser (1 shared paper)Alexander Vorog (1 shared paper)Brian Druker (1 shared paper)Ami B. Patel (1 shared paper)Philippe Rousselot (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)Blood (1 paper)Clinical Lymphoma Myeloma & Leukemia (2 papers)Medizinische Klinik - Intensivmedizin und Notfallmedizin (1 paper)Der Anaesthesist (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Michael Deininger
6 papers receiving 21 citations
Peers
Comparison fields: 5 of 13
- Hematology 14
- Genetics 9
- Rheumatology 5
- Pathology and Forensic Medicine 3
- Emergency Medicine 1
Countries citing papers authored by Michael Deininger
This map shows the geographic impact of Michael Deininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Deininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Deininger more than expected).
Fields of papers citing papers by Michael Deininger
This network shows the impact of papers produced by Michael Deininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Deininger. The network helps show where Michael Deininger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Deininger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 12 | |
| 2 | Molekulare therapie der CML - Eine neue ära in der behandlung maligner erkrankungen | 2002 | 3 |
| 3 | 2016 | 2 | |
| 4 | 2010 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 1 |
About Michael Deininger
Michael Deininger is a scholar working on Genetics, Hematology, Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 21 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Protein Degradation and Inhibitors (1 paper), Mechanical Circulatory Support Devices (1 paper), Airway Management and Intubation Techniques (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Hematology (14 citations), Genetics (9 citations), Rheumatology (5 citations), Pathology and Forensic Medicine (3 citations) and Emergency Medicine (1 citation). Michael Deininger has collaborated with scholars based in United States, Germany and France. Frequent co-authors include John M. Goldman, Joanna Góra‐Tybor, Junia V. Melo, Dietger Niederwieser, Alexander Vorog, Brian Druker, Ami B. Patel, Philippe Rousselot, Xiaowei Ren and Jörge E. Cortes. Their work appears in journals such as British Journal of Haematology, Blood, Clinical Lymphoma Myeloma & Leukemia, Medizinische Klinik - Intensivmedizin und Notfallmedizin and Der Anaesthesist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.